Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2020 | UK CAR-T: changing the landscape of lymphoma treatment

Andrea Kuhnl • 15 Jun 2020
EHA 2020
Lymphoma CAR-T

Andrea Kuhnl, MD, King’s College Hospital, London, United Kingdom, discusses the impact of CAR T-cell therapy on the treatment of lymphoma patients in the UK as well as potential pitfalls associated with their use. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Andrea Kuhnl

4:11
Evaluating radiotherapy bridging in patients with LBCL receiving CD19 CAR-T therapy
Andrea Kuhnl • 14 Jun 2023
10:22
CD19 CAR-T in lymphoma patients in the UK
Andrea Kuhnl • 23 May 2020
6:01
CD19 CAR-T for lymphoma: real-world experience in the UK
Andrea Kuhnl • 14 Jun 2020

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals